US Stock MarketDetailed Quotes

IMNM Immunome

Watchlist
  • 10.970
  • -0.110-0.99%
Close Dec 20 16:00 ET
  • 10.970
  • 0.0000.00%
Post 20:01 ET
684.71MMarket Cap-1.38P/E (TTM)

Immunome Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-18.37%2.91M
-44.55%2.36M
-56.47%1.03M
14.02M
3.83M
3.57M
4.26M
2.36M
0
0
Operating revenue
-18.37%2.91M
-44.55%2.36M
-56.47%1.03M
--14.02M
--3.83M
--3.57M
--4.26M
--2.36M
--0
--0
Cost of revenue
Gross profit
Operating expense
469.97%46.73M
259.32%36.06M
212.71%21.37M
15.84%42.75M
127.01%17.68M
-3.94%8.2M
12.44%10.04M
-41.35%6.84M
46.41%36.9M
-0.73%7.79M
Selling and administrative expenses
117.74%9.53M
61.53%6.98M
105.51%6.01M
44.23%19.66M
127.44%8.04M
32.22%4.38M
34.62%4.32M
-18.29%2.92M
22.85%13.63M
2.20%3.54M
-General and administrative expense
117.74%9.53M
61.53%6.98M
105.51%6.01M
44.23%19.66M
127.44%8.04M
32.22%4.38M
34.62%4.32M
-18.29%2.92M
22.85%13.63M
2.20%3.54M
Research and development costs
873.06%37.2M
408.80%29.08M
292.77%15.37M
-0.79%23.09M
126.65%9.64M
-26.83%3.82M
-0.02%5.72M
-51.56%3.91M
64.93%23.27M
-3.03%4.25M
Operating profit
-845.74%-43.82M
-483.70%-33.7M
-355.04%-20.35M
22.15%-28.73M
-77.87%-13.85M
45.71%-4.63M
35.32%-5.77M
61.64%-4.47M
-46.41%-36.9M
0.73%-7.79M
Net non-operating interest income expense
1,088.19%3.42M
1,699.54%3.89M
1,296.52%2.81M
54,380.00%2.72M
201,800.00%2.02M
28,700.00%288K
10,700.00%216K
20,000.00%201K
150.00%5K
120.00%1K
Non-operating interest income
1,088.19%3.42M
1,699.54%3.89M
1,296.52%2.81M
54,380.00%2.72M
201,800.00%2.02M
28,700.00%288K
10,700.00%216K
20,000.00%201K
--5K
--1K
Other net income (expense)
-6.71M
-6.31M
-111.95M
-80.8M
Special income (charges)
---6.71M
---6.31M
---111.95M
---80.8M
---80.8M
--0
--0
--0
--0
----
-Less:Other special charges
--6.71M
--6.31M
--111.95M
--80.8M
----
----
----
----
----
----
Income before tax
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
-189.48%-106.81M
-1,089.75%-92.63M
49.08%-4.35M
37.73%-5.56M
63.36%-4.27M
-49.31%-36.9M
0.84%-7.79M
Income tax
Net income
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
-189.48%-106.81M
-1,089.75%-92.63M
49.08%-4.35M
37.73%-5.56M
63.36%-4.27M
-49.31%-36.9M
0.84%-7.79M
Net income continuous Operations
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
-189.48%-106.81M
-1,089.75%-92.63M
49.08%-4.35M
37.73%-5.56M
63.36%-4.27M
-49.31%-36.9M
0.84%-7.79M
Minority interest income
Net income attributable to the parent company
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
-189.48%-106.81M
-1,089.75%-92.63M
49.08%-4.35M
37.73%-5.56M
63.36%-4.27M
-49.31%-36.9M
0.84%-7.79M
Preferred stock dividends
Other preferred stock dividends
0
622K
0
Net income attributable to common stockholders
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
-184.68%-106.81M
-1,089.75%-92.63M
52.54%-4.35M
37.73%-5.56M
63.36%-4.27M
-51.83%-37.52M
0.84%-7.79M
Basic earnings per share
-116.67%-0.78
-30.43%-0.6
-3,485.71%-12.55
-74.11%-5.38
-234.65%-2.1417
52.00%-0.36
37.84%-0.46
63.54%-0.35
-44.39%-3.09
1.54%-0.64
Diluted earnings per share
-116.67%-0.78
-30.43%-0.6
-3,485.71%-12.55
-74.11%-5.38
-234.65%-2.1417
52.00%-0.36
37.84%-0.46
63.54%-0.35
-44.39%-3.09
1.54%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -18.37%2.91M-44.55%2.36M-56.47%1.03M14.02M3.83M3.57M4.26M2.36M00
Operating revenue -18.37%2.91M-44.55%2.36M-56.47%1.03M--14.02M--3.83M--3.57M--4.26M--2.36M--0--0
Cost of revenue
Gross profit
Operating expense 469.97%46.73M259.32%36.06M212.71%21.37M15.84%42.75M127.01%17.68M-3.94%8.2M12.44%10.04M-41.35%6.84M46.41%36.9M-0.73%7.79M
Selling and administrative expenses 117.74%9.53M61.53%6.98M105.51%6.01M44.23%19.66M127.44%8.04M32.22%4.38M34.62%4.32M-18.29%2.92M22.85%13.63M2.20%3.54M
-General and administrative expense 117.74%9.53M61.53%6.98M105.51%6.01M44.23%19.66M127.44%8.04M32.22%4.38M34.62%4.32M-18.29%2.92M22.85%13.63M2.20%3.54M
Research and development costs 873.06%37.2M408.80%29.08M292.77%15.37M-0.79%23.09M126.65%9.64M-26.83%3.82M-0.02%5.72M-51.56%3.91M64.93%23.27M-3.03%4.25M
Operating profit -845.74%-43.82M-483.70%-33.7M-355.04%-20.35M22.15%-28.73M-77.87%-13.85M45.71%-4.63M35.32%-5.77M61.64%-4.47M-46.41%-36.9M0.73%-7.79M
Net non-operating interest income expense 1,088.19%3.42M1,699.54%3.89M1,296.52%2.81M54,380.00%2.72M201,800.00%2.02M28,700.00%288K10,700.00%216K20,000.00%201K150.00%5K120.00%1K
Non-operating interest income 1,088.19%3.42M1,699.54%3.89M1,296.52%2.81M54,380.00%2.72M201,800.00%2.02M28,700.00%288K10,700.00%216K20,000.00%201K--5K--1K
Other net income (expense) -6.71M-6.31M-111.95M-80.8M
Special income (charges) ---6.71M---6.31M---111.95M---80.8M---80.8M--0--0--0--0----
-Less:Other special charges --6.71M--6.31M--111.95M--80.8M------------------------
Income before tax -984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M-189.48%-106.81M-1,089.75%-92.63M49.08%-4.35M37.73%-5.56M63.36%-4.27M-49.31%-36.9M0.84%-7.79M
Income tax
Net income -984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M-189.48%-106.81M-1,089.75%-92.63M49.08%-4.35M37.73%-5.56M63.36%-4.27M-49.31%-36.9M0.84%-7.79M
Net income continuous Operations -984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M-189.48%-106.81M-1,089.75%-92.63M49.08%-4.35M37.73%-5.56M63.36%-4.27M-49.31%-36.9M0.84%-7.79M
Minority interest income
Net income attributable to the parent company -984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M-189.48%-106.81M-1,089.75%-92.63M49.08%-4.35M37.73%-5.56M63.36%-4.27M-49.31%-36.9M0.84%-7.79M
Preferred stock dividends
Other preferred stock dividends 0622K0
Net income attributable to common stockholders -984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M-184.68%-106.81M-1,089.75%-92.63M52.54%-4.35M37.73%-5.56M63.36%-4.27M-51.83%-37.52M0.84%-7.79M
Basic earnings per share -116.67%-0.78-30.43%-0.6-3,485.71%-12.55-74.11%-5.38-234.65%-2.141752.00%-0.3637.84%-0.4663.54%-0.35-44.39%-3.091.54%-0.64
Diluted earnings per share -116.67%-0.78-30.43%-0.6-3,485.71%-12.55-74.11%-5.38-234.65%-2.141752.00%-0.3637.84%-0.4663.54%-0.35-44.39%-3.091.54%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.